Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Royalty Pharma PLC (RPRX) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$578.66M
Net Income	$30.18M
Cost of Goods Sold	--
Gross Profit	$578.66M
Operating Expenses	$368.87M
Operating Income	$209.80M
Non-Operating Income/Expense	$-119.16M
Pre-Tax Income	$90.64M
Normalized Pre-Tax Income	$120.06M
Income after Taxes	$90.64M
Income from Continuous Operations	$90.64M
Consolidated Net Income/Loss	$90.64M
Normalized Income after Taxes	$120.06M
EBIT	$209.80M
EBITDA	$219.15M
Weighted-Average Shares Outstanding (Basic)	423.51M
Weighted-Average Shares Outstanding (Diluted)	562.30M
Earnings per Share (EPS) (Basic)	$0.07
Earnings per Share (EPS) (Diluted)	$0.07
Balance Sheet Financials
Current Assets	$1.52B
Property, Plant, and Equipment	$15.13B
Long-Term Assets	$16.80B
Total Assets	$18.32B
Current Liabilities	$1.21B
Long-Term Debt	$7.00B
Long-Term Liabilities	$7.61B
Total Liabilities	$8.82B
Common Equity	$9.50B
Tangible Shareholders Equity	$8.58B
Shareholders Equity	$9.50B
Common Shares Outstanding	992.25M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$960.06M
Cash Flow from Investing Activities	$191.94M
Cash Flow from Financial Activities	$-1.45B
Beginning Cash	$929.03M
End Cash	$631.91M
Increase/Decrease in Cash	$-297.12M
Stock-Based Compensation	$91.28M
Common Stock Dividends Paid	$-454.88M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.42
Debt to Equity Ratio	0.84
Gross Margin	100.00%
Operating Margin	36.26%
EBIT Margin	36.26%
EBITDA Margin	--
Pre-Tax Profit Margin	15.66%
Profit Margin	5.21%
Free Cash Flow	$957.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	--
Receiveable Turnover	20.86
Days Sales in Receivables	4.31
Return on Equity	0.95%
Return on Tangible Equity	1.06%
Return on Assets	0.49%
Return on Investments	0.55%
Book Value Per Share	$9.58
Free Cash Flow per Share	$1.70
Operating Cash Flow per Share	$1.71

Data from Zacks Investment Research, Inc.